Oxazinyl-Thiazolidinone Hybrids: Integrated Synthesis, Anticancer Activity, Molecular Docking and In-silico Pharmacokinetic Evaluation
- 17 March 2026
- journal article
- Published by World Scientific Pub Co Pte Ltd in Journal of Computational Biophysics and Chemistry
- Vol. 26 (02) , 1-23
Abstract
A series of 3-(6-(furan-2-yl)-4-(4-nitrophenyl)-6H-1,3-oxazin-2-yl)-2-phenylthiazolidin-4-one derivatives (15–19) were synthesized via a silica-supported method and comprehensively characterized using FT-IR, 1 H and [ ]C NMR and mass spectrometry. The anticancer potential of these thiazolidinone–oxazine hybrids was evaluated against the MCF-7 breast cancer cell line using the MTT assay. All compounds displayed moderate cytotoxic activity, with IC[ ] values ranging from 51.20 to 87.10 [ ]M. Among them, the nitro-substituted compound 15 exhibited the highest cytotoxic potency (IC[ ] 51.20 [ ]M), which may be attributed to the electron-withdrawing effect of the nitro group. To rationalize the experimental findings, molecular docking studies were performed against key breast cancer-related targets, including the estrogen receptor (2IOK), HER2 (7PCD), EGFR/SRC (1QCF) and HSP90 (8B7J). The docking results revealed strong binding interactions for all compounds, with compound 16 showing the highest docking affinity, while compound 15 demonstrated superior in-vitro cytotoxicity, highlighting the complementary nature of computational and biological evaluations. Furthermore, in silico ADME and toxicity analyses indicated favorable pharmacokinetic profiles, acceptable oral bioavailability and moderate predicted toxicity. All compounds satisfied Lipinski’s Rule of Five, falling within the optimal drug-like molecular weight range (200–500 g/mol), except compound 16. Overall, the combined experimental and computational results underscore the potential of oxazinyl–thiazolidinone scaffolds as promising lead candidates for the development of novel anti-breast cancer agents.Keywords
This publication has 38 references indexed in Scilit:
- New trends in synthetic drugs and natural products targeting 20S proteasomes in cancersBioorganic Chemistry, 2023
- Synthesis and biological evaluation of a ring analogs of the selective CB2 inverse agonist SMM-189Bioorganic & Medicinal Chemistry, 2021
- Compounds from the fruits of mangrove Sonneratia apetala: Isolation, molecular docking and antiaging effects using a Caenorhabditis elegans modelBioorganic Chemistry, 2020
- Effect of vildagliptin and pravastatin combination on cholesterol efflux in adipocytesIUBMB Life, 2016
- Synthesis of 3-phenylpyrazolopyrimidine-1,2,3-triazole conjugates and evaluation of their Src kinase inhibitory and anticancer activitiesBioorganic & Medicinal Chemistry Letters, 2011
- Privileged scaffolds for library design and drug discoveryCurrent Opinion in Chemical Biology, 2010
- Design, synthesis and anticancer activities of hybrids of indole and barbituric acids—Identification of highly promising leadsBioorganic & Medicinal Chemistry Letters, 2009
- Lead- and drug-like compounds: the rule-of-five revolutionDrug Discovery Today: Technologies, 2004
- Genetic Background but Not Metallothionein Phenotype Dictates Sensitivity to Cadmium-Induced Testicular Injury in MiceToxicology and Applied Pharmacology, 2001
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983